Saudi Food and Drug Authority would like to alert all consumers from buying medical devices through the internet which do not have SFDA marketing authorization .
2013-01-26
|
|
---|
Saudi food and drug authority, represented by sector of medical devices - Surveillance and Biometrics Department, and references to international regulatory authorities resources would like to warn all hospital and healthcare provider who use
" Circular Stapler " the existence of a counterfeit product labeled “ PROXIMATE® PPH Procedure for Prolapse and Hemorrhoids Set”.
For more information
|
|
---|
Saudi food and drug authority, represented by sector of medical device – Surveillance and Biometrics Department, would like to warn all hospitals and healthcare providers who use “ Covidien Nellcor SpO2 Dura-sensor DS-100A” the existence of a counterfeit product .
For more information
|
|
---|
SFDA Participates in the annual gathering and conference of the Asian Harmonization Organization AHWP, held in Philippines.
The chairman of the scientific & technical groups of the organization, the Executive Director of Radiological Health Department at SFDA, Engineer Ali Al Dalaan launched the associated activities, workshops and training of the annual gathering and conference wherein the scientific & technical groups and a number of international experts are participating.
The CEO of SFDA, Dr. Mohammed bin Abdul Rahman Almishal, confirmed that SFDA continues to implement its programs and development of its control regulations, which will help to protect the country and the citizen and residents from entry of any food or drugs or Medical devices to the Saudi markets, pointing out that SFDA electronic programs facilitated procedures, ensure accuracy and tightened its control over all products coming across the points of entry of the Kingdom.
Experts from 22 countries discussed during the 2nd day of World Health Organization Inter-Country Meeting on designing and implementing, SFDA experience in regulation and control of medical devices and products
The 2nd day of the conference organized by SFDA in coordination with WHO started with session 4 chaired by Josee Hansen, entitled Overview of Pre-Market Regulatory Controls.